Integer Holdings Corporation (ITGR)
NYSE: ITGR · Real-Time Price · USD
126.97
+0.27 (0.21%)
At close: Nov 16, 2026, 4:00 PM EST
126.97
0.00 (0.00%)
After-hours: Nov 16, 2026, 7:00 PM EST

Integer Holdings Revenue

Integer Holdings had revenue of $449.66M in the quarter ending October 2, 2026, a decrease of -3.86%. This brings the company's total for the last twelve months to $1.83B, down -0.31% year-over-year. In the year 2025, Integer Holdings had annual revenue of $1.85B with 7.98% growth. That makes Integer Holdings the 5,305th largest company in the world by revenue and 1,372nd in the United States.

Revenue (ttm)
$1.83B
Revenue Growth
-0.31%
P/S Ratio
2.36
Revenue / Employee
$165,946
Employees
11,000
Market Cap
4.32B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Cardio & Vascular 1.11B 59.7%
  • Cardiac Rhythm Management & Neuromodulation 668.80M 36.1%
  • Other Markets 77.75M 4.2%

By Geography

Chart
  • United States 979.81M 52.9%
  • Rest of World 569.05M 30.7%
  • Costa Rica 173.52M 9.4%
  • Puerto Rico 131.26M 7.1%
Fiscal year ended Dec 31, 2025 See the full Integer Holdings breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.85B137.04M7.98%
Dec 31, 20241.72B160.94M10.35%
Dec 31, 20231.56B224.38M16.85%
Dec 31, 20221.33B110.20M9.02%
Dec 31, 20211.22B147.64M13.75%
Dec 31, 20201.07B-184.65M-14.68%
Dec 31, 20191.26B43.08M3.55%
Dec 28, 20181.22B78.93M6.95%
Dec 29, 20171.14B60.58M5.63%
Dec 30, 20161.08B275.09M34.37%
Jan 1, 2016800.41M112.63M16.38%
Jan 2, 2015687.79M23.84M3.59%
Jan 3, 2014663.95M17.77M2.75%
Dec 28, 2012646.18M77.36M13.60%
Dec 30, 2011568.82M35.40M6.64%
Dec 31, 2010533.43M11.60M2.22%
Jan 1, 2010521.82M-24.82M-4.54%
Jan 2, 2009546.64M227.90M71.50%
Dec 28, 2007318.75M47.60M17.56%
Dec 29, 2006271.14M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Bruker3.51B
LivaNova1.51B
Haemonetics1.38B
Neogen884.00M
iRhythm Holdings854.04M
TransMedics Group727.65M
UFP Technologies649.52M
10x Genomics618.58M
Revenue Rankings